Coverage
-
September 26, 2014
The D.C. Circuit ruled Friday that the U.S. Food & Drug Administration didn't follow the proper procedure to revoke marketing clearance for a knee implant more than two years after it had initially granted it, finding the agency's inherent authority cannot trump Congress's rules for reclassifying medical devices.
1 other articles on this case.
View all »